258 related articles for article (PubMed ID: 5086706)
1. Tumor immunology.
Shehadeh IH
J Med Liban; 1972; 25(3):199-203. PubMed ID: 5086706
[No Abstract] [Full Text] [Related]
2. [Immunodepressive action of the tumor].
Belokhvostov AS
Vopr Onkol; 1978; 24(3):99-106. PubMed ID: 347712
[No Abstract] [Full Text] [Related]
3. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
4. The immunology of cancer.
Angel Basombrío M
J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
[No Abstract] [Full Text] [Related]
5. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
6. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
7. [Problems of tumor immunology and immunotherapy].
Schmidt CG
Helv Chir Acta; 1973 Mar; 40(1):77-86. PubMed ID: 4540691
[No Abstract] [Full Text] [Related]
8. Tumor-specific immunity.
Smith RT
Adv Pathobiol; 1976; 4():74-85. PubMed ID: 1023768
[No Abstract] [Full Text] [Related]
9. The immunology of cancer: avenues to immunotherapy.
Woods AH
Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414
[No Abstract] [Full Text] [Related]
10. Anesthesia and immunology.
Duncan PG; Cullen BF
Anesthesiology; 1976 Nov; 45(5):522-38. PubMed ID: 1086067
[No Abstract] [Full Text] [Related]
11. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
Kerbel RS
Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
[No Abstract] [Full Text] [Related]
12. [Immunological problems in oncology (author's transl)].
Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
[TBL] [Abstract][Full Text] [Related]
13. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
Rupniewska ZM; Adamczyk MB
Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
[No Abstract] [Full Text] [Related]
14. Tumor immunology.
Transplant Proc; 1975 Mar; 7(1 Suppl 1):473-555. PubMed ID: 1053512
[No Abstract] [Full Text] [Related]
15. Clinical aspects of cancer immunity.
Moore GE
Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
[No Abstract] [Full Text] [Related]
16. [Immunoreactivity in tumor growth].
Fel' VIa
Vopr Onkol; 1987; 33(4):99-106. PubMed ID: 3296438
[No Abstract] [Full Text] [Related]
17. [Why does a tumor grow?].
Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
[No Abstract] [Full Text] [Related]
18. [Immunochemical studies on tumors].
Grabar P
Arq Patol; 1969 Aug; 41(2):239-50. PubMed ID: 5403873
[No Abstract] [Full Text] [Related]
19. [New data on experimental tumor immunology].
Schneeweiss U; Gummel H
Z Exp Chir; 1972; 5(2):66-80. PubMed ID: 4680973
[No Abstract] [Full Text] [Related]
20. CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
Gregor PD; Wolchok JD; Ferrone CR; Buchinshky H; Guevara-Patiño JA; Perales MA; Mortazavi F; Bacich D; Heston W; Latouche JB; Sadelain M; Allison JP; Scher HI; Houghton AN
Vaccine; 2004 Apr; 22(13-14):1700-8. PubMed ID: 15068853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]